An exploratory analysis of efficacy and safety of abiraterone acetate (AA) in black patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) without prior chemotherapy (ctx)

被引：8

作者：

Efstathiou, Eleni ^{[1
]}

Deshpande, Hari ^{[2
]}

George, Daniel ^{[3
]}

Joshua, Anthony M. ^{[4
]}

Taplin, Mary-Ellen ^{[5
]}

Griffin, Thomas W. ^{[6
]}

Londhe, Anil ^{[7
]}

Todd, Mary ^{[8
]}

Molina, Arturo ^{[9
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Yale Univ, Ctr Canc, New Haven, CT USA

[3] Duke Univ, Med Ctr, Durham, NC USA

[4] Princess Margaret Canc Ctr, Toronto, ON, Canada

[5] Dana Farber Canc Inst, Boston, MA 02115 USA

[6] Janssen Res & Dev, Los Angeles, CA USA

[7] Janssen Res & Dev, Horsham, PA USA

[8] Janssen Global Serv, Raritan, NJ USA

[9] Janssen Res & Dev, Menlo Pk, CA USA

来源：

关键词：

D O I：

10.1158/1538-7445.AM2014-CT313

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CT313

引用

页数：2